Search Results - "Clerson, Pierre"

A Hemodynamic Study of Pulmonary Hypertension in Sickle Cell Disease by Parent, Florence, Bachir, Dora, Inamo, Jocelyn, Lionnet, François, Driss, Françoise, Loko, Gylna, Habibi, Anoosha, Bennani, Soumiya, Savale, Laurent, Adnot, Serge, Maitre, Bernard, Yaïci, Azzedine, Hajji, Leila, O'Callaghan, Dermot S, Clerson, Pierre, Girot, Robert, Galacteros, Frederic, Simonneau, Gerald

“…Patients with sickle cell disease underwent ECG with assessment of tricuspid valve regurgitant jet velocity (TRJV) to screen for pulmonary hypertension,…”
Get full text

Initial combination therapy of macitentan and tadalafil in pulmonary arterial hypertension by Sitbon, Olivier, Cottin, Vincent, Canuet, Matthieu, Clerson, Pierre, Gressin, Virginie, Perchenet, Loïc, Bertoletti, Laurent, Bouvaist, Hélène, Picard, François, Prévot, Grégoire, Bergot, Emmanuel, Simonneau, Gérald

“…Initial combination therapy plays a central role in managing pulmonary arterial hypertension (PAH) [1–4]. Patients with low- or intermediate-risk of 1-year…”
Get full text

Survival in systemic sclerosis-associated pulmonary arterial hypertension in the modern management era by Launay, David, Sitbon, Olivier, Hachulla, Eric, Mouthon, Luc, Gressin, Virginie, Rottat, Laurence, Clerson, Pierre, Cordier, Jean-François, Simonneau, Gerald, Humbert, Marc

“…To assess the survival and prognostic factors in patients with newly diagnosed incident systemic sclerosis (SSc)-associated pulmonary arterial hypertension…”
Get more information

Prevalence of HIV-related Pulmonary Arterial Hypertension in the Current Antiretroviral Therapy Era by Sitbon, Olivier, Lascoux-Combe, Caroline, Delfraissy, Jean-Francois, Yeni, Patrick G, Raffi, Francois, De Zuttere, Dominique, Gressin, Virginie, Clerson, Pierre, Sereni, Daniel, Simonneau, Gerald

“…The prevalence of HIV-associated pulmonary arterial hypertension (PAH) has not been evaluated since introduction of combined, highly active antiretroviral…”
Get full text

Clinical phenotypes and survival of pre-capillary pulmonary hypertension in systemic sclerosis by Launay, David, Montani, David, Hassoun, Paul M, Cottin, Vincent, Le Pavec, Jérôme, Clerson, Pierre, Sitbon, Olivier, Jaïs, Xavier, Savale, Laurent, Weatherald, Jason, Sobanski, Vincent, Mathai, Stephen C, Shafiq, Majid, Cordier, Jean-François, Hachulla, Eric, Simonneau, Gérald, Humbert, Marc

“…Pre-capillary pulmonary hypertension (PH) in systemic sclerosis (SSc) is a heterogeneous condition with an overall bad prognosis. The objective of this study…”
Get full text

Natural history of ischemic digital ulcers in systemic sclerosis: single-center retrospective longitudinal study by HACHULLA, Eric, CLERSON, Pierre, LAUNAY, David, LAMBERT, Marc, MORELL-DUBOIS, Sandrine, QUEYREL, Viviane, HATRON, Pierre-Yves

“…OBJECTIVE: To describe the natural history of ischemic digital ulcers (DU) in systemic sclerosis (SSc). METHODS: This single-center, retrospective,…”
Get full text

Is pulmonary arterial hypertension really a late complication of systemic sclerosis? by Hachulla, Eric, Launay, David, Mouthon, Luc, Sitbon, Olivier, Berezne, Alice, Guillevin, Loïc, Hatron, Pierre-Yves, Simonneau, Gérald, Clerson, Pierre, Humbert, Marc

“…Pulmonary arterial hypertension (PAH) is a frequent cause of morbidity and mortality in patients with systemic sclerosis (SSc). PAH is generally considered to…”
Get more information

Clinical Characteristics and Survival in Systemic Sclerosis-Related Pulmonary Hypertension Associated With Interstitial Lung Disease by Launay, David, MD, PhD, Humbert, Marc, MD, PhD, Berezne, Alice, MD, Cottin, Vincent, MD, PhD, Allanore, Yannick, MD, PhD, Couderc, Louis-Jean, MD, Bletry, Olivier, MD, Yaici, Azzedine, MD, Hatron, Pierre-Yves, MD, Mouthon, Luc, MD, PhD, Le Pavec, Jérôme, MD, PhD, Clerson, Pierre, MD, Hachulla, Eric, MD, PhD

“…Background Pulmonary hypertension (PH) complicating systemic sclerosis (SSc)-related interstitial lung disease (ILD) is usually associated with a poor…”
Get full text

Evaluation of serum thymidine kinase 1 activity as a biomarker for treatment effectiveness and prediction of relapse in dogs with non‐Hodgkin lymphoma by Boyé, Pierre, Floch, Franck, Serres, François, Geeraert, Kévyn, Clerson, Pierre, Siomboing, Xavier, Bergqvist, Mattias, Sack, Gabriel, Tierny, Dominique

“…Background Serum thymidine kinase 1 (sTK1) activity is closely correlated with DNA synthesis. Objectives Evaluate sTK1 activity as a biomarker for treatment…”
Get full text

Accuracy of the HumaSensplus point-of-care uric acid meter using capillary blood obtained by fingertip puncture by Fabre, Stnphanie, Clerson, Pierre, Launay, Jean-Marie, Gautier, Jean-Francois, Vidal-Trecan, Tiphaine, Riveline, Jean-Pierre, Platt, Adam, Abrahamsson, Anna, Miner, Jeffrey N, Hughes, Glen, Richette, Pascal, Bardin, Thomas

“…BACKGROUNDThe uric acid (UA) level in patients with gout is a key factor in disease management and is typically measured in the laboratory using plasma samples…”
Get full text

Clinical Features of Scleroderma Patients With or Without Prior or Current Ischemic Digital Ulcers: Post-Hoc Analysis of a Nationwide Multicenter Cohort (ItinérAIR-Sclérodermie) by PHONG TIEV, Kiet, DIOT, Elisabeth, CLERSON, Pierre, DUPUIS-SIMEON, Frédérique, HACHULLA, Eric, HATRON, Pierre-Yves, CONSTANS, Joel, CIRSTEA, Daniéla, FARGE-BANCEL, Dominique, CARPENTIER, Patrick H

“…Objective. Digital ulcers are the most frequent vascular manifestations of systemic sclerosis (SSc). Clinical features of patients with prior or current…”
Get full text

Value of systolic pulmonary arterial pressure as a prognostic factor of death in the systemic sclerosis EUSTAR population by Hachulla, Eric, Clerson, Pierre, Airò, Paolo, Cuomo, Giovanna, Allanore, Yannick, Caramaschi, Paola, Rosato, Edoardo, Carreira, Patricia E, Riccieri, Valeria, Sarraco, Marta, Denton, Christopher P, Riemekasten, Gabriela, Pozzi, Maria Rosa, Zeni, Silvana, Mihai, Carmen Marina, Ullman, Susanne, Distler, Oliver, Rednic, Simona, Smith, Vanessa, Walker, Ulrich A, Matucci-Cerinic, Marco, Müller-Ladner, Ulf, Launay, David

“…The aim of this study was to assess the prognostic value of systolic pulmonary artery pressure (sPAP) estimated by echocardiography in the multinational…”
Get full text

Relationship between 25-OH-D serum level and relapse rate in multiple sclerosis patients before and after vitamin D supplementation by Pierrot-Deseilligny, Charles, Rivaud-Péchoux, Sophie, Clerson, Pierre, de Paz, Raphaël, Souberbielle, Jean-Claude

“…Background: Vitamin D could play a protective role in multiple sclerosis. Methods: In an observational, uncontrolled study, vitamin D3 supplementation (3010…”
Get full text

Controlling the digital ulcerative disease in systemic sclerosis is associated with improved hand function by Mouthon, Luc, MD, PhD, Carpentier, Patrick H., MD, Lok, Catherine, MD, Clerson, Pierre, MD, Gressin, Virginie, MD, Hachulla, Eric, MD, PhD, Bérezné, Alice, MD, Diot, Elisabeth, MD, PhD, Van Kien, Aurélie Khau, MD, Jego, Patrick, MD, PhD, Agard, Christian, MD, PhD, Duval-Modeste, Anne Bénédicte, MD, Sparsa, Agnès, MD, PhD, Puzenat, Eve, MD, Richard, Marie-Aleth, MD, PhD

“…Abstract Objectives Ischemic digital ulcers (DU) represent a major complication of systemic sclerosis (SSc). We investigated the impact of controlling the…”
Get full text

Optimization of heart FailUre medical Treatment after hospital discharge according to left ventricUlaR Ejection fraction: The FUTURE survey by Cohen Solal, Alain, Leurs, Irina, Assyag, Patrick, Beauvais, Florence, Clerson, Pierre, Contre, Christine, Thebaut, Jean-François, Genoun, Maxime

“…Summary Background No clinical practice guidelines are available for the treatment of heart failure (HF) in patients with preserved left ventricular ejection…”
Get full text

Predictive factors for masked hypertension within a population of controlled hypertensives by Mallion, Jean-Michel, Clerson, Pierre, Bobrie, Guillaume, Genes, Nathalie, Vaisse, Bernard, Chatellier, Gilles

“…CONTEXTPrevalence of masked hypertension (MH) is far from negligible reaching 40% in some studies. The SHEAF study (Self measurement of blood pressure at Home…”
Get full text

EVAPIL-R Scale: Continuous Development and Validation of a Tool to Assess Patient-Reported Tolerability of Different Contraceptive Methods in Longitudinal Studies by Clerson, Pierre, MD, Graesslin, Olivier, MD, Gater, Adam, MSc, Taylor, Fiona, MBiochem, Filonenko, Anna, DrPH, Schellschmidt, Ilka, MD, Rosen, Kimberly, MD

“…Abstract Background Objective: The objective of this study was to modify the EVAPIL, a questionnaire designed to assess user-reported tolerability of combined…”
Get full text

Epidemiology of gout and hyperuricemia in New Caledonia by Bardin, Thomas, Magnat, Elodie, Clerson, Pierre, Richette, Pascal, Rouchon, Bernard

“…•This study is the first to estimate the prevalence of gout in New Caledonia, a multiethnic Pacific island.•The prevalence of gout was 3.3% (95% confidence…”
Get full text

Revisiting comorbidities in gout: a cluster analysis by Richette, Pascal, Clerson, Pierre, Périssin, Laure, Flipo, René-Marc, Bardin, Thomas

“…The reciprocal links between comorbidities and gout are complex. We used cluster analysis to attempt to identify different phenotypes on the basis of…”
Get more information

Screening for pulmonary arterial hypertension in patients with systemic sclerosis: Clinical characteristics at diagnosis and long‐term survival by Humbert, Marc, Yaici, Azzedine, de Groote, Pascal, Montani, David, Sitbon, Olivier, Launay, David, Gressin, Virginie, Guillevin, Loïc, Clerson, Pierre, Simonneau, Gérald, Hachulla, Eric

“…Objective Pulmonary arterial hypertension (PAH) is a severe, life‐limiting complication of systemic sclerosis (SSc). Guidelines recommend early detection and…”
Get full text